Ensysce BiosciencesENSC
13F holders, Q1 2025 (March 31)9holders +1
2new positions
1sold out
$2.56avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Ensysce Biosciences Inc. (ENSC) in their 13F filings, up 1 from Q4 2024. 2 opened new positions and 1 sold out. The largest holders were Murchinson Ltd. ($358K), Perceptive Advisors LLC ($222K) and Adage Capital Partners Gp, L.L.C. ($191K).
- Company
- Ensysce Biosciences Inc.
- CUSIP
- 293602504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $479K |
| Exits | 1 | $423 |
All 13F filers, Q4 2024 → Q1 2025: 212,382 shares bought and 52 shares sold, net +212,330 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Murchinson Ltd. | 0.06% | New | 140,000 | $358K |
| Perceptive Advisors LLC | 0.01% | No change | 86,666 | $222K |
| Adage Capital Partners Gp, L.L.C. | 0.00% | Add +49.4% | 74,711 | $191K |
| Sabby Management, LLC | 0.50% | New | 46,954 | $120K |
| FNY Investment Advisers, LLC | 0.00% | No change | 3,000 | $7K |
| UBS Group AG | 0.00% | Add +119.8% | 1,308 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.7% | 441 | $1K |
| BlackRock, Inc. | 0.00% | Add +1.6% | 65 | $166 |
| Bank of America Corp. | 0.00% | No change | 8 | $20 |
"% of holder's portfolio" is ENSC's weight in each manager's 13F, not the share of Ensysce Biosciences Inc. the manager owns.